Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Aptamer wins contract with 'top 10' repeat customer

(Sharecast News) - Life sciences group Aptamer on Monday announced a new fee-for-service development contract with an unnamed top 10 global pharma company. The contract, valued at £112,000, represents "success-based repeat business with an existing partner", Aptamer said.

It will focus on the development of Aptamer's Optimer binders against two protein targets to support the partner's internal biomarker research.

"This work paves the way for additional revenue for ELISA assay development and builds on our proven success with a top 5 pharma partner in this space," said chief executive Arron Tolley.

Shares were up 0.4% at 1.05p by 1035 BST.

Share this article

Related Sharecast Articles

Magnum Ice Cream results fail to impress as operating profit slides
(Sharecast News) - Shares in Magnum Ice Cream tumbled on Thursday as its first full-year results since the recent demerger from Unilever failed to impress.
THG strikes deal with Greencore to sell protein-enriched convenience foods
(Sharecast News) - THG is to target the booming obesity jab market through a strategic partnership with convenience food producer Greencore Group, it confirmed on Thursday.
RBC Capital Markets lowers target price on Barratt Redrow
(Sharecast News) - Analysts at RBC Capital Markets lowered their target price on property developer Barratt Redrow from 450p to 425p on Thursday as it updated its estimates to account for the firm's interim results.
GPE secures major pre‑let at The Delft with AI firm Quantexa
(Sharecast News) - Property developer Great Portland Estates has pre-let of 52,293 square feet at The Delft, SE1 to global data, analytics, and AI software company Quantexa.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.